Otospon (Ciprofloxacin, Fluocinolone)

Ciprofloxacin, the active ingredient in Otospon, is a fluoroquinolone antibiotic presented as a topical ear preparation for otic use. It treats bacterial ear infections and reduces inflammation in the middle and outer ear. GNH USA supplies Otospon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otospon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otospon combines ciprofloxacin and fluocinolone to address bacterial and inflammatory conditions of the ear. It is indicated for: - Acute otitis externa: reduces bacterial load and inflammation, promoting faster symptom relief. - Chronic otitis media with effusion: helps control infection and inflammation in the middle ear. - Post‑surgical ear care: prevents bacterial colonisation and reduces postoperative inflammation. - External auditory canal dermatitis: alleviates inflammatory skin changes while treating secondary bacterial infection. - Eustachian tube dysfunction related otitis: assists in managing infection‑driven inflammation. - Ear canal fungal fungi (only if bacterial superinfection present): provides antibacterial coverage alongside anti‑inflammatory action.

Otospon may cause local and systemic adverse reactions. Patients should be monitored for any signs of intolerance.

Common Side Effects: - Ear itching or mild irritation. - Burning sensation in the ear canal. - Temporary hearing changes. - Mild headache. - Localised redness or swelling. - Dryness of the ear canal.

Serious or Rare Side Effects: - Severe ototoxicity or hearing loss. - Allergic reaction such as rash, urticaria, or angio‑edema. - Persistent otorrhea with foul odor. - Secondary fungal infection of the ear. - Systemic hypersensitivity reactions. - Vision changes or ocular irritation if product contacts eye.

Before using Otospon, consider the following safety measures: - Contraindication: Do not use if there is a known hypersensitivity to ciprofloxacin, fluocinolone or any excipients. - Pregnancy: Use only if clearly indicated. - Breastfeeding: Caution advised; assess risk‑benefit. - Auditory function: Monitor hearing if treatment exceeds 7‑7 days. - Ear surgery: Avoid use in perforated tympanic membrane unless directed by a specialist. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Otospon may interact with other otic medications and systemic agents. Review :

Major Interactions (Avoid): - Co‑administration with aminoglycoside otic drops : increased risk of ototoxicity. - Concurrent systemic fluoroquinolones : potential additive tendon‑related effects. - Use with topical non‑steroidal anti‑inflammatory drugs (NSAIDs) : reduced anti‑inflammatory efficacy.

Moderate Interaction :  - Systemic corticost steroids : enhanced systemic steroid exposure. - Anticoagulants : possible increase in bleeding risk. - Anticholinergic : potential dry ear effects . -  -  -